- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04438746
Chronic Pain, Opioids, and Anger Treatment
Alleviating Pain and Opioid Dependence Through Anger Management: A Pilot Study
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Participants will be recruited by electronic announcements and IRB approved recruitment flyers in local pain clinics and pain support groups. These ads and flyers will contain relevant info (e.g., study email address and GoogleVoice number) for prospective participants to contact study staff with any questions about participation. Interested participants will be screened by an RA on the phone using the following steps: 1) RA will obtain verbal consent upon explaining study participation and answering any questions participants may have; 2) Once informed consent is obtained, RA will use participants preferred email address to send potential participant a link to the Qualtrics screening questionnaire; 3) RA will then briefly orient participant to Qualtrics; and 3) RA will complete the screening process with participant on the phone to determine and inform participant of their eligibility to participate.
Consent and Screening: Participants will first go through the informed consent procedure, where they will be told about the purpose of the study, expectations of them as participants, etc. Informed consent is expected to take no more than 5 minutes. They will then be asked to complete a screening questionnaire which is expected to take no more than 3 minutes. Eligible participants will be randomly assigned to one of two groups: 1) Control and 2) CBAT. Both control group and experimental group participants will be required to complete 2 pre-recorded sessions per week lasting 1 hour each (total of 8 hours) over the course of 4 weeks.
Online Sessions and Surveys: After questionnaires (including measures of pain and opioid use, the Anger Parameters Scale) have been administered at pre-treatment, the first session will serve as orientation to self-monitoring anger levels between sessions. If a participant has no anger on a given day, no monitoring is necessary. Following this, control group participants self-monitor their anger and watch pre-recorded sessions on emotions in general. The treatment group will be actively trained in anger regulation skills within the framework of CBAT. These participants will proceed from a week of anger prevention to a week of intervention to a week of postvention. During the prevention phase, an individually-tailored behavior contract against anger will be signed by each paParticipants will work with investigators over email to draft and electronically sign their contracts. RAs will review participant progress toward fulfillment of contracts during weekly check-in phone calls to participants. Participants will also engage in behavioral rehearsal of anger-provoking situations and learn about stimulus control for discriminating and avoiding situations that are likely to culminate in anger.
In the Intervention phase, participants will be introduced to techniques for regulating anger that could not be prevented. These include thought-stopping, distraction, and cognitive reappraisal..
In the postvention phase, participants will be trained in techniques for ameliorating residual anger. These include expressive writing and verbal disclosure. Gestalt therapy empty chair dialogue will be used for overcoming unresolved anger.
At the conclusion of the 4 weeks of anger self-regulation training, the same questionnaires relating to anger, pain, and opioid misuse and beliefs will be assessed in both groups. This post-treatment set of questionnaires is expected to take no more than 20 minutes.
Finally, a follow-up session (2 hours) will be held for both groups one month after post-treatment. Anger, pain, and opioid use measures will be re-administered (taking no more than 20 minutes). All participants will receive a brief booster session to reinforce effective anger regulation techniques. The same pre- and post-treatment questionnaires mentioned above will be re-administered at this point in the study.
Phone Calls and Knowledge Tests: To ensure that participants are paying attention to the online videos, RAs will contact them weekly and administer a brief, multiple choice knowledge test over the phone. Participants who score less than 50% in any given week will be dropped from the study. During that same phone call, RAs will check in with participants to ensure that there are no problems with their participation in the study and that the participants are not in any emotional distress. Phone calls are anticipated to last approximately 10 minutes, for a total time of 50 minutes over the span of the study (4 weeks of either treatment or control and the 1-month follow up). Total participant time commitment over the course of the study is approximately 12 hours.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Texas
-
San Antonio, Texas, Verenigde Staten, 78249
- University of Texas at San Antonio
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- taking opioid pain relievers for at least 3 months in the past 12 months
- maladaptive levels of anger as measured by STAXI-2
- without psychiatric co-morbidity (e.g., major depression, substance use disorder, etc.)
- not undergoing current psychological/psychiatric treatment
- speak English.
Exclusion Criteria:
-
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Group receiving CBAT
|
Active training in regulating anger
|
Placebo-vergelijker: Group receiving general emotion training
|
General discussion of emotions; no therapy or training is offered
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change in pain medication dosage and frequency of use at one month
Tijdsspanne: One month
|
Participants are asked what pain medication they are using and at what dosage and frequency.
Open-ended question.
|
One month
|
Change in pain medication dosage and frequency of use at one month follow-up
Tijdsspanne: One month after end of intervention
|
Participants are asked what pain medication they are using and at what dosage and frequency.
Open-ended question.
|
One month after end of intervention
|
Change in attitudes/beliefs surrounding pain medication at one month
Tijdsspanne: One month
|
Assessed using the Pain Medication Beliefs Questionnaire (Schieffer et al., 2005), a five-item instrument measuring beliefs about one's response to, relief from, and potential addiction to pain medication
|
One month
|
Change in attitudes/beliefs surrounding pain medication at one month follow-up
Tijdsspanne: One month after end of intervention
|
Assessed using the Pain Medication Beliefs Questionnaire (Schieffer et al., 2005), a five-item instrument measuring beliefs about one's response to, relief from, and potential addiction to pain medication
|
One month after end of intervention
|
Change in opioid misuse at one month
Tijdsspanne: One month
|
Measured with the Current Opioid Misuse Measure (Butler et al., 2007), a 17-item instrument assessing signs and symptoms of drug misuse, emotional/psychiatric problems due to misuse, evidence of lying about drug use, and other domains
|
One month
|
Change in opioid misuse at one month follow-up
Tijdsspanne: One month after end of intervention
|
Measured with the Current Opioid Misuse Measure (Butler et al., 2007), a 17-item instrument assessing signs and symptoms of drug misuse, emotional/psychiatric problems due to misuse, evidence of lying about drug use, and other domains
|
One month after end of intervention
|
Change in anger parameters at one month
Tijdsspanne: One month
|
The Anger Parameters Scale taps into five parameters: Frequency, Duration, Intensity, Latency, and Threshold (Fernandez et al., 2014). Scores can range from 0-120 and higher scores imply more maladaptive anger. The APS is comprised of 30 items rated from 0-4. The total possible score ranges from 0 to 120. A higher score on the APS indicates more maladaptive anger. |
One month
|
Change in anger parameters at one month follow-up
Tijdsspanne: One month after end of intervention
|
The Anger Parameters Scale taps into five parameters: Frequency, Duration, Intensity, Latency, and Threshold (Fernandez et al., 2014).
Scores can range from 0-120 and higher scores imply more maladaptive anger.
|
One month after end of intervention
|
Change in anger expression style at one month
Tijdsspanne: One month
|
Measured with the Anger Expression Scale (Fernandez, 2008).
The AES is comprised of 60 items rated from 0-4.
These items are organized into 12 sub-scales of 5 items each.
These sub-scales have a minimum total possible score of 0 and a maximum of 20.
Higher scores on each sub-scale (as well as a higher cumulative score) indicates more maladaptive anger.
|
One month
|
Change in anger expression style at one month follow-up
Tijdsspanne: One month after end of intervention
|
Measured with the Anger Expression Scale (Fernandez, 2008).
The AES is comprised of 60 items rated from 0-4.
These items are organized into 12 sub-scales of 5 items each.
These sub-scales have a minimum total possible score of 0 and a maximum of 20.
Higher scores on each sub-scale (as well as a higher cumulative score) indicates more maladaptive anger.
|
One month after end of intervention
|
Change in chronic pain ratings at one month
Tijdsspanne: One month
|
Single item measured on a scale from 0-10
|
One month
|
Change in chronic pain ratings at one month follow up
Tijdsspanne: One month after end of intervention
|
Single item measured on a scale from 0-10
|
One month after end of intervention
|
Change in emotional response to chronic pain at one month
Tijdsspanne: One month
|
Single item measured on a scale from "a little unpleasant" to "extremely distressing"
|
One month
|
Change in emotional response to chronic pain at one month follow-up
Tijdsspanne: One month after end of intervention
|
Single item measured on a scale from "a little unpleasant" to "extremely distressing"
|
One month after end of intervention
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Ephrem Fernandez, PhD, University of Texas at San Antonio
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- #20-002
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .